Neonatal infections (part 2): How the NeoSep1 trial will help treat sick newborns

Neonatal sepsis is a life-threatening infection that affects up to 3 million babies per year globally.

In an effort to identify better treatments, the NeoSep1 clinical trial evaluates new antibiotic combinations for newborn babies with sepsis. To learn more about the trial, we speak to Adrie Bekker and Cristina Obiero, principal investigators of the trial in South Africa and Kenya, Reenu Thomas, a neonatologist from South Africa, and Francesca Schiavone, the clinical project manager of the NeoSep1 trial in London.
-

Further information about the NeoSep1 clinial trial is available at www.mrcctu.ucl.ac.uk and https://gardp.org/.

For questions or feedback on the series, message us at [email protected]

For more information and to access the transcript: https://bit.ly/3MSKkw5

As a listener, your opinion is very valuable to us. Please help us to improve the podcast in future by filling in this short survey: https://forms.office.com/e/PjfjQ5Mn6g